<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 03 Aug 2026 05:49:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 3, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), today announced financial results for the first half ending &lt;chron&gt;June 30, 2026&lt;/chron&gt; (&quot;Reporting Period&quot;). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Financial Highlights&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;H1 2026 total revenue reached &lt;money&gt;RMB 28.90 billion&lt;/money&gt;, up 38.9% YoY; revenue from Continuing Operations&lt;sup&gt;[2]&lt;/sup&gt; up 48.0% YoY.&lt;/li&gt;&lt;li&gt;Adjusted non-IFRS gross profit margin</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Delivers+Strong+H1+2026+Results+and+Raises+Full-Year+Guidance%5B1%5D%2C+Driven+by+Greater+Success+of+Multiple+Customers%27+Products+and+CRDMO+Model/26852735.html</guid>
   <pubDate>Mon, 03 Aug 2026 05:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36670513</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year</title>
   <link>http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 21, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained commitment to sustainability.&lt;/p&gt;
&lt;p&gt;The FTSE4Good Index Series, created by the global index and data provider FTSE Russell, is a family of equity indices designed to assess and track the performance of companies demonstrating strong sustainability practices, serving as a benchmark for investors seeking to encourage positive change in corporate behavior and align their portfolios with their values. In</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/WuXi+AppTec+Named+Constituent+of+the+FTSE4Good+Index+Series+for+Fourth+Consecutive+Year/26796817.html</guid>
   <pubDate>Tue, 21 Jul 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
  <item>
   <title>WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index</title>
   <link>http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Recognized+as+a+Top-Performing+Company+on+2026+Dow+Jones+Best-in-Class+World+Index/26508993.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/cn..shangh&quot; idsrc=&quot;xmltag.org&quot; &gt;SHANGHAI&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 17, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt;, a leading global pharmaceutical CRDMO (&lt;span&gt;Contract Research&lt;/span&gt;, Development, and &lt;span&gt;Manufacturing Organization&lt;/span&gt;), has been selected for the 2026 Dow Jones Best-in-Class World Index (DJ BIC World Index, formerly Dow Jones Sustainability World Index), which recognizes the top-performing companies in each industry on long-term sustainability criteria. This recognition reflects progress that &lt;span value=&quot;Shanghai:603259&quot; idsrc=&quot;xmltag.org&quot; &gt;WuXi AppTec&lt;/span&gt; has made in integrating responsible sustainability practices across its operations and strategies.&lt;/p&gt;
&lt;p&gt;The Dow Jones Best-in-Class World Index, administered by S&amp;amp;P Global through its Corporate Sustainability Assessment (CSA), selects companies</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WuXi+AppTec+Recognized+as+a+Top-Performing+Company+on+2026+Dow+Jones+Best-in-Class+World+Index/26508993.html</guid>
   <pubDate>Sun, 17 May 2026 20:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2359</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">603259</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012010</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08483209</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22094343</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.62017196</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WUXAY</category>
   	  </item>
 </channel>
</rss>
